
Bruce F Bell
Examiner (ID: 11075)
Most Active Art Unit | 1741 |
Art Unit(s) | 1741, 1754, 1746, 1745, 2734, 1795, 1759, 1102 |
Total Applications | 2788 |
Issued Applications | 2338 |
Pending Applications | 153 |
Abandoned Applications | 297 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17603992
[patent_doc_number] => 11332463
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-17
[patent_title] => Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors
[patent_app_type] => utility
[patent_app_number] => 17/049653
[patent_app_country] => US
[patent_app_date] => 2019-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36515
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17049653
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/049653 | Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors | Apr 28, 2019 | Issued |
Array
(
[id] => 16786072
[patent_doc_number] => 10988484
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-27
[patent_title] => Glucose uptake inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/397043
[patent_app_country] => US
[patent_app_date] => 2019-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 16
[patent_no_of_words] => 61463
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 277
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16397043
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/397043 | Glucose uptake inhibitors | Apr 28, 2019 | Issued |
Array
(
[id] => 16915794
[patent_doc_number] => 20210188886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => A GOLD(III) COMPLEX, A CONJUGATE OF THE GOLD(III) COMPLEX, A PHARMACEUTICAL COMPOSITION COMPRISING THE GOLD(III) COMPLEX AND USES AND A PROCESS FOR PREPARING THE GOLD(III) COMPLEX
[patent_app_type] => utility
[patent_app_number] => 17/050512
[patent_app_country] => US
[patent_app_date] => 2019-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5239
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17050512
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/050512 | Gold(III) complex, a conjugate of the gold(III) complex, a pharmaceutical composition comprising the gold(III) complex and uses and a process for preparing the gold(III) complex | Apr 28, 2019 | Issued |
Array
(
[id] => 15147609
[patent_doc_number] => 20190352282
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => NOVEL MCT4 INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/395099
[patent_app_country] => US
[patent_app_date] => 2019-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9048
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16395099
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/395099 | MCT4 inhibitors and uses thereof | Apr 24, 2019 | Issued |
Array
(
[id] => 15405341
[patent_doc_number] => 20200022992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => CONJUGATE COMPOUNDS OF URSODEOXYCHOLIC, BERBERINE OR L-CARNITINE, AND COMPOSITIONS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/392385
[patent_app_country] => US
[patent_app_date] => 2019-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9685
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16392385
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/392385 | CONJUGATE COMPOUNDS OF URSODEOXYCHOLIC, BERBERINE OR L-CARNITINE, AND COMPOSITIONS AND METHODS THEREOF | Apr 22, 2019 | Abandoned |
Array
(
[id] => 16869930
[patent_doc_number] => 20210163397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => NOVEL DICARBOXYLIC ACID DIESTERS
[patent_app_type] => utility
[patent_app_number] => 17/047883
[patent_app_country] => US
[patent_app_date] => 2019-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4340
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17047883
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/047883 | Dicarboxylic acid diesters | Apr 22, 2019 | Issued |
Array
(
[id] => 16711884
[patent_doc_number] => 20210079031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => NEW ANTIVIRAL ACYCLONUCLEOSIDE ANALOGUES
[patent_app_type] => utility
[patent_app_number] => 17/050263
[patent_app_country] => US
[patent_app_date] => 2019-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19118
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 257
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17050263
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/050263 | Antiviral acyclonucleoside analogues for use in treating a viral infection | Apr 22, 2019 | Issued |
Array
(
[id] => 18028900
[patent_doc_number] => 11512072
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-29
[patent_title] => Compositions and methods for preparing and using azetidines
[patent_app_type] => utility
[patent_app_number] => 17/048500
[patent_app_country] => US
[patent_app_date] => 2019-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10567
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17048500
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/048500 | Compositions and methods for preparing and using azetidines | Apr 18, 2019 | Issued |
Array
(
[id] => 14929785
[patent_doc_number] => 20190300530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => FUSED INDAZOLE PYRIDONE COMPOUNDS AS ANTIVIRALS
[patent_app_type] => utility
[patent_app_number] => 16/383382
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42001
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 524
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16383382
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/383382 | FUSED INDAZOLE PYRIDONE COMPOUNDS AS ANTIVIRALS | Apr 11, 2019 | Abandoned |
Array
(
[id] => 16870000
[patent_doc_number] => 20210163467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => MORPHOLINE DERIVATES AS INHIBITORS OF VPS34
[patent_app_type] => utility
[patent_app_number] => 17/046750
[patent_app_country] => US
[patent_app_date] => 2019-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20155
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17046750
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/046750 | Morpholine derivates as inhibitors of Vps34 | Apr 8, 2019 | Issued |
Array
(
[id] => 16621465
[patent_doc_number] => 20210040118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => IMMUNOMODULATORS, COMPOSITIONS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/041455
[patent_app_country] => US
[patent_app_date] => 2019-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11776
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17041455
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/041455 | IMMUNOMODULATORS, COMPOSITIONS AND METHODS THEREOF | Apr 2, 2019 | Abandoned |
Array
(
[id] => 16597994
[patent_doc_number] => 20210024525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/040104
[patent_app_country] => US
[patent_app_date] => 2019-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62073
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 408
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17040104
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/040104 | Compounds for treating Huntington's disease | Mar 26, 2019 | Issued |
Array
(
[id] => 16332689
[patent_doc_number] => 20200303655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME
[patent_app_type] => utility
[patent_app_number] => 16/761902
[patent_app_country] => US
[patent_app_date] => 2019-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12360
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 341
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16761902
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/761902 | Compound and organic light emitting device comprising same | Mar 21, 2019 | Issued |
Array
(
[id] => 15279995
[patent_doc_number] => 10512647
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-24
[patent_title] => Small molecule regulators of steroid receptor coactivators and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/361600
[patent_app_country] => US
[patent_app_date] => 2019-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18605
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16361600
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/361600 | Small molecule regulators of steroid receptor coactivators and methods of use thereof | Mar 21, 2019 | Issued |
Array
(
[id] => 16807755
[patent_doc_number] => 20210130308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => MODULATORS OF EUKARYOTIC INITIATION FACTOR 2
[patent_app_type] => utility
[patent_app_number] => 16/982471
[patent_app_country] => US
[patent_app_date] => 2019-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37999
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -58
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16982471
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/982471 | MODULATORS OF EUKARYOTIC INITIATION FACTOR 2 | Mar 21, 2019 | Abandoned |
Array
(
[id] => 15468447
[patent_doc_number] => 10550086
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-02-04
[patent_title] => Lenvatinib derivative, and composition for pharmaceutical research and tumor therapeutic agent using the same
[patent_app_type] => utility
[patent_app_number] => 16/360528
[patent_app_country] => US
[patent_app_date] => 2019-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2943
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16360528
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/360528 | Lenvatinib derivative, and composition for pharmaceutical research and tumor therapeutic agent using the same | Mar 20, 2019 | Issued |
Array
(
[id] => 14962933
[patent_doc_number] => 20190308944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => NOVEL ARYL OR HETEROARYL TRIAZOLONE DERIVATIVES OR SALTS THEREOF, OR PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/359984
[patent_app_country] => US
[patent_app_date] => 2019-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54593
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16359984
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/359984 | Aryl or heteroaryl triazolone derivatives or salts thereof, or pharmaceutical compositions comprising the same | Mar 19, 2019 | Issued |
Array
(
[id] => 16628648
[patent_doc_number] => 20210047301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => 2-CYANOPYRIMIDIN-4-YL CARBAMATE OR UREA DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME
[patent_app_type] => utility
[patent_app_number] => 17/041883
[patent_app_country] => US
[patent_app_date] => 2019-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22093
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17041883
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/041883 | 2-cyanopyrimidin-4-yl carbamate or urea derivative or salt thereof, and pharmaceutical composition including same | Mar 19, 2019 | Issued |
Array
(
[id] => 14867801
[patent_doc_number] => 20190284142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => KV7 CHANNEL ACTIVATORS COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/358642
[patent_app_country] => US
[patent_app_date] => 2019-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38172
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16358642
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/358642 | Kv7 channel activators compositions and methods of use | Mar 18, 2019 | Issued |
Array
(
[id] => 16598023
[patent_doc_number] => 20210024554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => CRYSTALLINE FORMS AND METHODS OF PRODUCING CRYSTALLINE FORMS OF A COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/982022
[patent_app_country] => US
[patent_app_date] => 2019-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11636
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16982022
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/982022 | Crystalline forms and methods of producing crystalline forms of a compound | Mar 17, 2019 | Issued |